{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:06:10Z","timestamp":1794135970072,"version":"4.8.0"},"reference-count":30,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2020,8,18]]},"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1136\/ejhpharm-2020-002374","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T17:25:28Z","timestamp":1602609928000},"page":"207-211","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study"],"prefix":"10.1136","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8605-1313","authenticated-orcid":false,"given":"Noelia","family":"Fern\u00e1ndez-Bargiela","sequence":"first","affiliation":[{"name":"Service of Pharmacy, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rotea-Salvo","sequence":"additional","affiliation":[{"name":"Service of Pharmacy, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Margusino-Frami\u00f1\u00e1n","sequence":"additional","affiliation":[{"name":"Service of Pharmacy, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"},{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Balboa-Barreiro","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics Unit, Biomedical Research Institute of A Coru\u00f1a (INIBIC), Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a (UDC), A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mart\u00edn-Herranz","sequence":"additional","affiliation":[{"name":"Service of Pharmacy, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Castro-Iglesias","sequence":"additional","affiliation":[{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"},{"name":"Service of Infectious Internal Medicine, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Mena-De-Cea","sequence":"additional","affiliation":[{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"},{"name":"Service of Infectious Internal Medicine, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"L\u00f3pez-Calvo","sequence":"additional","affiliation":[{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"},{"name":"Service of Infectious Internal Medicine, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"V\u00e1zquez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"},{"name":"Service of Infectious Internal Medicine, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"M\u00edguez-Rey","sequence":"additional","affiliation":[{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"},{"name":"Service of Infectious Internal Medicine, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-8002","authenticated-orcid":false,"given":"Purificaci\u00f3n","family":"Cid-Silva","sequence":"additional","affiliation":[{"name":"Service of Pharmacy, Universitary Hospital of A Coru\u00f1a (CHUAC), SERGAS, A Coru\u00f1a, Spain"},{"name":"Division of Clinical Virology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), University Hospital of A Coru\u00f1a (CHUAC), SERGAS, Universitary of A Coru\u00f1a, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"2025090702045406000_29.4.207.1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/0956462417750708","article-title":"Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UK","volume":"29","author":"Chaponda","year":"2018","journal-title":"Int J STD AIDS"},{"key":"2025090702045406000_29.4.207.2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002227"},{"key":"2025090702045406000_29.4.207.3","first-page":"87","article-title":"Estudio piloto para desarrollar Y validar un cuestionario basado en El \u00edndice de s\u00edntomas de VIH","volume":"03","author":"Ibarra-Barrueta","year":"2019","journal-title":"Farm Hosp"},{"key":"2025090702045406000_29.4.207.4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.5.725"},{"key":"2025090702045406000_29.4.207.5","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0132-4"},{"key":"2025090702045406000_29.4.207.6","first-page":"13","article-title":"FDA approves Sustiva (efavirenz) capsules, first once-daily anti-HIV drug. Food and drug administration","volume":"4","year":"1998","journal-title":"Res Initiat Treat Action"},{"key":"2025090702045406000_29.4.207.7","unstructured":"European Medicines Agency . Sustiva, 2018. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sustiva"},{"key":"2025090702045406000_29.4.207.8","unstructured":"Panel de expertos GeSIDA y Plan Nacional sobre el Sida . Documento de consenso de GeSIDA\/Plan nacional sobre el sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualizaci\u00f3n enero 2019). Available: http:\/\/gesida-seimc.org\/wp-content\/uploads\/2019\/02\/Guia_Tar_Gesida_Ene_2019.pdf"},{"key":"2025090702045406000_29.4.207.9","unstructured":"Panel Members of European AIDS Clinical Society (EACS) . European guidelines for treatment of HIV-positive adults in Europe version 10.0, 2019. Available: https:\/\/www.eacsociety.org\/files\/2019_guidelines-10.0_final.pdf"},{"key":"2025090702045406000_29.4.207.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70257-3"},{"key":"2025090702045406000_29.4.207.11","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/S2352-3018(15)00027-2","article-title":"Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3B study","volume":"2","author":"Molina","year":"2015","journal-title":"Lancet HIV"},{"key":"2025090702045406000_29.4.207.12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu051"},{"key":"2025090702045406000_29.4.207.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"2025090702045406000_29.4.207.14","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3166"},{"key":"2025090702045406000_29.4.207.15","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30095-4"},{"key":"2025090702045406000_29.4.207.16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","article-title":"Dolutegravir plus abacavir\u2013lamivudine for the treatment of HIV-1 infection","volume":"369","author":"Walmsley","year":"2013","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025090702045406000_29.4.207.17","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12468"},{"key":"2025090702045406000_29.4.207.18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bcpt.12828","article-title":"Clinical experience with the integrase inhibitors dolutegravir and elvitegravir in HIV-infected patients: efficacy, safety and tolerance","volume":"121","author":"Cid-Silva","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2025090702045406000_29.4.207.19","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1097\/QAD.0000000000001279","article-title":"Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice","volume":"30","author":"de Boer","year":"2016","journal-title":"AIDS"},{"key":"2025090702045406000_29.4.207.20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAD.0000000000001357","article-title":"Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients","volume":"31","author":"Borghetti","year":"2017","journal-title":"AIDS"},{"key":"2025090702045406000_29.4.207.21","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2013.773067"},{"key":"2025090702045406000_29.4.207.22","doi-asserted-by":"publisher","DOI":"10.1310\/3Q91-YT2D-BUT4-8HN6"},{"key":"2025090702045406000_29.4.207.23","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200203010-00004"},{"key":"2025090702045406000_29.4.207.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31824e5256"},{"key":"2025090702045406000_29.4.207.25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/hiv.12710","article-title":"Discontinuation of dolutegravir, elvitegravir\/cobicistat and raltegravir because of toxicity in a prospective cohort","volume":"20","author":"Llibre","year":"2019","journal-title":"HIV Med"},{"key":"2025090702045406000_29.4.207.26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00228-018-2472-y","article-title":"Adverse reactions associated with first-line regimens in patient initiating antiretroviral therapy","volume":"74","author":"Mendes","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"2025090702045406000_29.4.207.27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QAD.0000000000001351","article-title":"Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir","volume":"31","author":"Bonfanti","year":"2017","journal-title":"AIDS"},{"key":"2025090702045406000_29.4.207.28","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283612419"},{"key":"2025090702045406000_29.4.207.29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QAI.0000000000001269","article-title":"Psychiatric symptoms in patients receiving dolutegravir","volume":"74","author":"Fettiplace","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025090702045406000_29.4.207.30","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9896-z"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2020-002374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:05:09Z","timestamp":1757235909000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2020-002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,6,23]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/ejhpharm-2020-002374"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2020-002374","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}